本次出售事项有利于本公司回收部份资金以用于解决运营资金问题及减少投资负担。经考虑上述进行出 售事项的理由及裨益后，董事认为股权转让协议的条款属公平合理，且出售事项符合本公司及其股东的 整体利益。 近年来，国家先后出台多项政策，指导职业教育高质量发展，本集团院校面临较大办学投入压力。出售 事项将更好地帮助本集团筹集资金，使本集团能够更好地调配财务资源，改善办学条件以满足现有院校 基本办学、院校改扩建等需求。 希教国际控股(01765)发布公告，于2025年11月16日，买方西安典振实业、卖方四川署瑞企业管理(本公 司的全资附属公司)、目标公司西安倍诺思教育与买方担保人订立股权转让协议，卖方已有条件同意转 让而买方已有条件同意以人民币1000万元的转让代价收购目标公司100%股权及其附属实体权益;及目标 公司已有条件同意偿还借款。买方及买方担保人已同意就目标公司的还款责任提供不可撤回的连带担 保。 目标公司主要从事教育管理及教育行业投资。出售事项完成后，目标公司将不再为本集团的附属公司， 其财务业绩、资产及负债将不再并入本集团的综合财务报表。 ...

SBA Group company Utenos Trikotažas on November 4, 2025, completed a transaction selling a controlling stake in its Ukrainian subsidiary Mrija, which provides sewing services. The company sold 98.87 percentage points out of its total 98.95 percent shareholding, as well as its rights of claim related to the subsidiary. The transaction was carried out in accordance with a court-approved restructuring plan, which stipulated the sale of this asset. The shares of Mrija and the related rights of claim were acqui ...

Summary of ReShape Lifesciences Inc. Special Meeting Company Overview - **Company**: ReShape Lifesciences Inc. (RSLS) - **Date of Meeting**: August 07, 2025 - **Key Participants**: Paul Hickey (CEO), Tom Stankovich (CFO), Brett Hansen (Legal Counsel), Christina Vico (Inspector of Elections) Core Proposals Discussed 1. **Proposal Two**: Approval for the sale of substantially all of ReShape's assets - This proposal was a key focus of the meeting and was presented for voting [2][5] 2. **Proposal Three**: Approval and adoption of proposed amendments to ReShape's certificate of incorporation in connection with the proposed merger with Viome Therapeutics - This proposal was also highlighted for stockholder voting [2][5] Voting Process - The meeting was reconvened to allow stockholders to vote on the two proposals after a prior adjournment on July 24, 2025 [2][3] - Stockholders were informed that they could vote via a web portal or had the option to change their votes if they had already submitted them [4] - A quorum was confirmed to be present for the conduct of business [3] Preliminary Results - Preliminary results indicated that both proposals were approved by the stockholders [6] - The final vote tally is to be reported in a Form 8-K to be filed with the SEC within four business days following the meeting [6] Additional Notes - The meeting was conducted in a structured manner with designated roles for the participants, ensuring a formal process for the voting and discussion of proposals [3] - The focus on asset sale and merger indicates a significant strategic shift for ReShape Lifesciences, which may impact its future operations and market positioning [2][5]

Core Viewpoint - Intel is exploring the sale of its "NEX" network and edge division [1] Group 1 - The decision to explore a sale indicates a strategic shift within Intel [1] - The potential sale could impact Intel's overall business structure and focus [1] - This move may reflect broader trends in the technology sector regarding network and edge computing [1]